TD Cowen analyst Gary Taylor lowered the firm’s price target on UnitedHealth to $562 from $596 and keeps an Outperform rating on the shares. The analyst said we are reducing forward EPS estimates as we assume lower MA rates for 2024 and incremental 1% margin compression for OptumHealth capitated revenues in both 2024-2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on UNH:
- Rob Arnott Says It’s Time to Buy Into Value Stocks; Here Are 2 Names That Analysts Like
- UnitedHealth says Optum RX experienced another strong growth season
- UnitedHealth Gains after Q1 Earnings Beat and Raised Outlook
- UnitedHealth raises FY23 adjusted EPS view to $24.50-$25.00 from $24.40-$24.90
- UnitedHealth reports Q1 adjusted EPS $6.26, consensus $6.13